AbbVie – The 2023 Humira Patent Cliff Looms
If you’re a dividend investor you’re probably quite familiar with AbbVie. The stock is known for its high dividend yield and high dividend growth, a combination that is rare in today’s stock market. The massive cash flows that have enabled such generous dividend increases are primarily fueled by one drug: Humira. With its loss of …